IART

INTEGRA LIFESCIENCES HLDGS C

IART·457985208·US·Common Stock·Healthcare - Medical Devices-13D/G

IART (INTEGRA LIFESCIENCES HLDGS C) is held by 118 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($97.2M), VANGUARD PORTFOLIO MANAGEMENT LLC ($34.7M), MORGAN STANLEY ($33.8M). Net institutional sentiment: Mixed.

118
Holders
(10 Elite)
$545M
Total Value
50% (115)
Consensus
58 buying - 57 selling
13F: Insider & Congress:
IART

Smart Money Verdict

View all
Held by 118 funds
10 elite

Who's Trading

ActivistVPVanguard Portfolio Management5.0%Jul 31, 2026
ActivistPIPARADIGM CAPITAL MANAGEMENT INC/NY5.2%May 15, 2026
InsiderBKBRADLEY KEITHTax 882 shMay 9, 2026
InsiderHBHILL BARBARA BVest 18K shMay 7, 2026
InsiderHBHILL BARBARA BVest 7K shMay 7, 2026
ActivistThe Vanguard GroupThe Vanguard Group0.0%Mar 27, 2026
InsiderGAGRAVES JEFFREY ABuy $102KNov 5, 2025
CongressJosh GottheimerJosh GottheimerSale $1,001 - $15,000Jun 18, 2024
CongressJosh GottheimerJosh GottheimerSale $1,001 - $15,000Apr 5, 2024

Top Holders

Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
10.3M(-0.3%)$97.2M0.0%-22.85%
0
New
3.7M$34.7M0.0%+63.35%
40
Decreased
3.6M(-6.9%)$33.8M0.0%-40.42%
0
Decreased
3.5M(-2.9%)$33.2M0.1%-33.88%
0
Decreased
3.5M(-1.1%)$32.8M0.0%-37.15%
0
New
2.9M$27.2M0.0%+63.35%
40
Increased
2.9M(+2.6%)$27.2M0.0%-54.49%
29
Decreased
2.8M(-10.1%)$26.1M0.0%-51.82%
0
Increased
2.1M(+1.8%)$19.9M0.0%-21.24%
29
Increased
1.9M(+30.7%)$17.7M0.0%-10.92%
36
Decreased
1.7M(-1.6%)$15.6M0.0%-55.92%
0
Increased
1.6M(+3.4%)$15.2M0.0%-43.27%
29
Increased
1.4M(+71.4%)$13.3M0.0%+7.71%
42
Decreased
1.3M(-3.9%)$12.2M0.0%-61.08%
0
Increased
984,686(+27.4%)$9.3M0.0%-33.52%
34
Increased
889,604(+36.7%)$8.4M0.0%+24.31%
36
Increased
765,273(+2.0%)$7.2M0.0%-52.68%
28
Increased
694,076(+409.3%)$6.5M0.0%+56.67%
44
Increased
622,853(+318.1%)$5.9M0.0%+42.67%
44
Increased
476,701(+86.3%)$4.5M0.0%+47.47%
42

Showing 1-20 of 129

1 / 7
IARTIARTINTEGRA LIFESCIENCES HLDGS C

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used